---
title: "Patient Safety Screener-3 Associations With Depression and Suicide Risk in Japanese Resident Physi"
id: "medrxiv-2-associations-of-the-patient-safety-screener-3-with-depression-and-suicide-risk"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-2-associations-of-the-patient-safety-screener-3-with-depression-and-suicide-risk"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1?rss=1"
published_at: "2026-08-31T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Patient Safety Screener-3 Associations With Depression and Suicide Risk in Japanese Resident Physi
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-2-associations-of-the-patient-safety-screener-3-with-depression-and-suicide-risk
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1?rss=1)
- **Published At:** 2026-08-31T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This nationwide cross-sectional survey evaluated the **Patient Safety Screener-3 (PSS-3)** among 1,844 resident physicians in Japan to examine links between a depressive mood item and depressive symptom severity and to characterize suicide-related risk captured by PSS-3 total positivity. - PSS-3 item 1 asks about **depressive mood** but is not included in the PSS-3 total score; the study assessed its association with PHQ-9 scores using the Wilcoxon rank-sum test and diagnostic performance against PHQ-9 positivity (score ≥10). - Of 1,844 participants, 443 (24.0%) endorsed PSS-3 item 1; 47 participants (2.5%) met criteria for PSS-3 total positivity. - Using PHQ-9 positivity (≥10) as the reference, PSS-3 item 1 showed 79.3% sensitivity and 79.5% specificity for detecting depressive symptoms at that threshold. - The Short-form Scale for Suicide Ideation (**SIS-6**) scores were significantly higher in the PSS-3 total-positive group compared with the total-negative group (median [IQR] 6 [5–9] vs 0 [0–1]; p < 0.001), indicating greater suicide-related ideation among PSS-3 total-positive respondents. - Receiver operating characteristic analyses found that SIS-6 better discriminated PSS-3 total positivity (AUC 0.961; optimal cutoff 3) than PHQ-9 item 9 positivity (AUC 0.907; optimal cutoff 2), suggesting PSS-3 total positivity captures a more severe spectrum of suicide-related risk than PHQ-9 item 9 alone. - The authors conclude the **PSS-3** may facilitate brief simultaneous screening for depressive symptoms and suicide-related risk and may help identify individuals needing further mental health assessment. - Ethical approval was obtained from the Ethics Review Board of the Japan Institute for Advancement of Medical Education Program (approval number 25-11). Raw data are not publicly available but can be requested from the corresponding author. - Competing interests: several authors received honoraria related to JAMEP; HT, SF, YN, and YT were not involved in data analysis. Funding sources included multiple foundations and JSPS/JST grants as declared.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=5tOL_vQ0GazStBuBf.AYpBuUwDtHXSi6nehMniiOP5s-1788245826.0691214-1.2.1.1-12FE1t8ocr8y77xydFH79dJ9Uokhl0BGDgjIyefotIBMrEjnJkb.PEIV4N2ezHLr) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Associations of the Patient Safety Screener-3 With Depression and Suicide Risk: A Nationwide Cross-Sectional Study in Japan [ View ORCID Profile](http://orcid.org/0009-0002-8004-1445)Kana Kiryu, [ View ORCID Profile](http://orcid.org/0000-0002-5581-5720)Hidetaka Tamune, [ View ORCID Profile](http://orcid.org/0009-0005-4859-2812)Keitaro Takahashi, [ View ORCID Profile](http://orcid.org/0000-0002-8195-1267)Hirohisa Fujikawa, [ View ORCID Profile](http://orcid.org/0009-0001-1820-9422)Hiroyuki Harada, Sho Fukui, [ View ORCID Profile](http://orcid.org/0000-0002-8312-7802)Kazuya Nagasaki, Yuji Nishizaki, [ View ORCID Profile](http://orcid.org/0000-0001-7856-3952)Tadafumi Kato, [ View ORCID Profile](http://orcid.org/0000-0002-9325-7934)Yasuharu Tokuda doi: https://doi.org/10.64898/2026.08.30.26361711 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Kana Kiryu 1 Juntendo University Graduate School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kana%2BKiryu%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kiryu%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKana%2BKiryu%2B) * [ORCID record for Kana Kiryu](http://orcid.org/0009-0002-8004-1445 "Open in new tab") Hidetaka Tamune 1 Juntendo University Graduate School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hidetaka%2BTamune%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tamune%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHidetaka%2BTamune%2B) * [ORCID record for Hidetaka Tamune](http://orcid.org/0000-0002-5581-5720 "Open in new tab") * For correspondence: hidetaka.tamune@juntendo.ac.jp Keitaro Takahashi 1 Juntendo University Graduate School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Keitaro%2BTakahashi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Takahashi%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKeitaro%2BTakahashi%2B) * [ORCID record for Keitaro Takahashi](http://orcid.org/0009-0005-4859-2812 "Open in new tab") Hirohisa Fujikawa 1 Juntendo University Graduate School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hirohisa%2BFujikawa%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fujikawa%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHirohisa%2BFujikawa%2B) * [ORCID record for Hirohisa Fujikawa](http://orcid.org/0000-0002-8195-1267 "Open in new tab") Hiroyuki Harada 1 Juntendo University Graduate School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hiroyuki%2BHarada%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Harada%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHiroyuki%2BHarada%2B) * [ORCID record for Hiroyuki Harada](http://orcid.org/0009-0001-1820-9422 "Open in new tab") Sho Fukui 2 Kyorin University School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sho%2BFukui%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fukui%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASho%2BFukui%2B) Kazuya Nagasaki 3 Fujita Health University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kazuya%2BNagasaki%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nagasaki%20K&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKazuya%2BNagasaki%2B) * [ORCID record for Kazuya Nagasaki](http://orcid.org/0000-0002-8312-7802 "Open in new tab") Yuji Nishizaki 1 Juntendo University Graduate School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yuji%2BNishizaki%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nishizaki%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYuji%2BNishizaki%2B) Tadafumi Kato 1 Juntendo University Graduate School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Tadafumi%2BKato%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kato%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATadafumi%2BKato%2B) * [ORCID record for Tadafumi Kato](http://orcid.org/0000-0001-7856-3952 "Open in new tab") Yasuharu Tokuda 4 Muribushi Okinawa Center for Teaching Hospitals * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yasuharu%2BTokuda%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tokuda%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYasuharu%2BTokuda%2B) * [ORCID record for Yasuharu Tokuda](http://orcid.org/0000-0002-9325-7934 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1289368/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1289368/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1289368/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1289368/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1289368/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1289368/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Aim: The Patient Safety Screener-3 (PSS-3) is a brief suicide-risk screening tool. Item 1 of this scale assesses depressive mood but is not included in the total score. We examined the association of item 1 with depressive symptom severity and characterized the suicide-related risk captured by PSS-3 total positivity. Methods: We conducted a nationwide cross-sectional survey among resident physicians in Japan. Associations between PSS-3 item 1 endorsement and Patient Health Questionnaire-9 (PHQ-9) scores were evaluated using the Wilcoxon rank-sum test. Diagnostic performance of item 1 was evaluated using PHQ-9 positivity (≥10) as reference standard. We also compared Short-form Scale for Suicide Ideation (SIS-6) scores according to PSS-3 total positivity and PHQ-9 item 9 positivity. Results: A total of 1,844 participants were included. PSS-3 item 1 was endorsed by 443 physicians (24.0%), and 47 (2.5%) met the criteria for PSS-3 total positivity. Item 1 showed 79.3% sensitivity and 79.5% specificity for PHQ-9 positivity. SIS-6 scores were higher in the PSS-3 total-positive group than in the total-negative group (median [IQR], 6 [5-9] vs 0 [0-1]; p The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.29.26361710v1 "The timeline of brain aging in major depression: A prospective study from before first-onset to established illness")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.27.26361471v1 "Trends in incidence and antimicrobial resistance for five major causes of bacteraemia in a Canadian metropolitan area, 2006–22: a genomic and antimicrobial use cohort study") Posted August 31, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/31/2026.08.30.26361711.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.08.30.26361711v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/31/2026.08.30.26361711.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Associations of the Patient Safety Screener-3 With Depression and Suicide Risk: A Nationwide Cross-Sectional Study in Japan Kana Kiryu, Hidetaka Tamune, Keitaro Takahashi, Hirohisa Fujikawa, Hiroyuki Harada, Sho Fukui, Kazuya Nagasaki, Yuji Nishizaki, Tadafumi Kato, Yasuharu Tokuda medRxiv 2026.08.30.26361711; doi: https://doi.org/10.64898/2026.08.30.26361711 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.30.26361711v1%26text%3DAssociations%2520of%2520the%2520Patient%2520Safety%2520Screener-3%2520With%2520Depression%2520and%2520Suicide%2520Risk%253A%2520A%2520Nationwide%2520Cross-Sectional%2520Study%2520in%2520Japan "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.30.26361711v1%26t%3DAssociations%2520of%2520the%2520Patient%2520Safety%2520Screener-3%2520With%2520Depression%2520and%2520Suicide%2520Risk%253A%2520A%2520Nationwide%2520Cross-Sectional%2520Study%2520in%2520Japan "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.30.26361711v1%26title%3DAssociations%2520of%2520the%2520Patient%2520Safety%2520Screener-3%2520With%2520Depression%2520and%2520Suicide%2520Risk%253A%2520A%2520Nationwide%2520Cross-Sectional%2520Study%2520in%2520Japan%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.30.26361711v1%26title%3DAssociations%2520of%2520the%2520Patient%2520Safety%2520Screener-3%2520With%2520Depression%2520and%2520Suicide%2520Risk%253A%2520A%2520Nationwide%2520Cross-Sectional%2520Study%2520in%2520Japan "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.30.26361711) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.30.26361711v1&count=horizontal&via=&text=Associations%20of%20the%20Patient%20Safety%20Screener-3%20With%20Depression%20and%20Suicide%20Risk%3A%20A%20Nationwide%20Cross-Sectional%20Study%20in%20Japan&counturl=www.medrxiv.org/content/10.64898/2026.08.30.26361711v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (613) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (895) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (326) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4766) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (474) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (406) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (643) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1613) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15828) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1194) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6980) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (727) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1057) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4974) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1425) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-an
## Related Clinical Research

- [Adjusting unmet need for contraception by including husband’s virility in the Revised algorithm](https://medichelpline.com/clinical-feed/plos-one-2-incorporating-husband-s-influence-in-estimating-unmet-need-for-contraception.md)
- [End-of-life symptom prevalence and drivers among hospital decedents in South Korea](https://medichelpline.com/clinical-feed/plos-one-3-prevalence-and-influencing-factors-of-end-of-life-symptoms-among-hospital.md)
- [Multiple Long-Term Conditions in India: Prevalence, Quality of Life Impact, and Healthcare Use](https://medichelpline.com/clinical-feed/bmj-open-7-multiple-long-term-conditions-and-their-association-with-quality-of-life-and.md)
- [Antenatal depression prevalence and associated factors in post-war Shire, Tigray, Ethiopia](https://medichelpline.com/clinical-feed/medrxiv-3-magnitude-of-antenatal-depression-among-women-attending-antenatal-care-at.md)
- [Nurse Practitioner Trainees Face Clinical Mentor Shortage and Preceptor Challenges](https://medichelpline.com/clinical-feed/stat-news-3-nurse-practitioner-trainees-find-themselves-stymied-by-shortage-of-clinical.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.